Pluri (PLUR) Cash & Equivalents (2010 - 2025)
Pluri (PLUR) posted quarterly Cash & Equivalents of $4.7 million for Q4 2025, down 35.12% year-over-year from $7.2 million in Q4 2024, and up 10.12% quarter-over-quarter from $4.3 million in Q3 2025.
Pluri (PLUR) Cash & Equivalents (2010 - 2025) Analysis & Trends
Pluri (PLUR) has reported Cash & Equivalents for 16 consecutive years, with $4.7 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Cash & Equivalents fell 35.12% year-over-year to $4.7 million; the TTM figure through Dec 2025 stood at $4.7 million (down 35.12% YoY), while the FY2025 annual figure was $5.9 million, down 13.09% from the prior year.
- Cash & Equivalents advanced to $4.7 million in Q4 2025 per PLUR's latest filing, from $4.3 million in the prior quarter.
- Across five years, Cash & Equivalents topped out at $31.8 million in Q2 2021 and bottomed at $633000.0 in Q1 2023.
- Historically, Cash & Equivalents has averaged $9.8 million across 5 years, with a median of $7.6 million in 2024.
- Annual changes were most pronounced in 2021 — Cash & Equivalents soared 47955.0% — and 2023, when it sank 97.46%.
- Pluri's Cash & Equivalents stood at $19.2 million in 2021, then plunged by 54.13% to $8.8 million in 2022, then plunged by 88.46% to $1.0 million in 2023, then soared by 610.12% to $7.2 million in 2024, then sank by 35.12% to $4.7 million in 2025.
- Business Quant data shows PLUR's Cash & Equivalents at $4.7 million in Q4 2025, $4.3 million in Q3 2025, and $5.9 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 6.14 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 2.46 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 3.58 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 1.72 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 5.10 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 1.71 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 8.93 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 544.80 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 811.99 Mn |
| 10 | Pluri | 16.21 Mn | 3.72 Mn | 86,000.00 | 4.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 4.69 Mn |
| Sep 30, 2025 | 4.26 Mn |
| Jun 30, 2025 | 5.90 Mn |
| Mar 31, 2025 | 8.50 Mn |
| Dec 31, 2024 | 7.23 Mn |
| Sep 30, 2024 | 3.20 Mn |
| Jun 30, 2024 | 6.78 Mn |
| Mar 31, 2024 | 7.99 Mn |
| Dec 31, 2023 | 1.02 Mn |
| Sep 30, 2023 | 5.25 Mn |
| Jun 30, 2023 | 6.26 Mn |
| Mar 31, 2023 | 633,000.00 |
| Dec 31, 2022 | 8.82 Mn |
| Sep 30, 2022 | 10.03 Mn |
| Jun 30, 2022 | 11.41 Mn |
| Mar 31, 2022 | 24.93 Mn |
| Dec 31, 2021 | 19.22 Mn |
| Sep 30, 2021 | 15.22 Mn |
| Jun 30, 2021 | 31.84 Mn |
| Mar 31, 2021 | 12.27 Mn |